CONNECT WITH US
Funding Tracker

Funding Tracker

Wellbeing Nutrition’s revenue doubles to Rs 244 Cr in FY26, losses widen to Rs 92 Cr

Entrackr logo

Published on

Add as a preferred source on Google
Wellbeing Nutrition’s revenue doubles to Rs 244 Cr in FY26, losses widen to Rs 92 Cr

Clean-label nutraceutical brand Wellbeing Nutrition more than doubled its revenue in FY26, while its losses widened 2.4X to Rs 92 crore. The financial performance comes just after pharmaceutical major USV acquired a 79% stake in the company.

According to financial statements reviewed by Entrackr, Wellbeing Nutrition’s revenue from operations grew to Rs 244 crore in FY26 from Rs 118 crore in FY25.

Founded in 2019, Wellbeing Nutrition operates in the nutraceutical segment, offering products across vitamins, minerals, protein, collagen, omega supplements and other wellness categories. The company sells through its own website, online marketplaces and offline retail channels, and has a presence in markets such as the US, UK and UAE.

Product sales were the company’s sole source of operating revenue during the year. Its portfolio includes collagen supplements, oral strips, marine collagen, slow-release capsules and effervescent tablets.

On the cost side, advertising and promotional expenses surged 78.7% to Rs 109 crore in FY26 from Rs 61 crore in FY25, accounting for around 32% of the company’s total expenditure. Meanwhile, the cost of materials consumed more than doubled to Rs 106 crore during the year.

Other expenses, including freight, commissions, legal fees and overheads, pushed the company’s total expenditure to Rs 338 crore in FY26, up 115.3% from Rs 157 crore in FY25.

As a result, Wellbeing Nutrition’s losses increased to Rs 92 crore in FY26 from Rs 38 crore in the previous fiscal year, despite the strong growth in revenue.


Source link
Related Topics:Funding Tracker

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.